130 related articles for article (PubMed ID: 3919978)
21. Antigen-specific and nonspecific interferon response of peripheral blood leukocytes from patients with chronic brucellosis.
Inglot AD; Dobracki W; Piasecki E; Sypulła A; Gładysz A
Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):203-11. PubMed ID: 2129383
[TBL] [Abstract][Full Text] [Related]
22. Differences in interferon-gamma response of psoriatic lymphocytes to stimulation with various mitogens.
Goan SR; Volk HD; Eichhorn I; Diezel W
Biomed Biochim Acta; 1986; 45(7):903-6. PubMed ID: 3024630
[TBL] [Abstract][Full Text] [Related]
23. [Lymphocyte transformation responses to mitogens and specific antigens in patients with multiple sclerosis].
Shen G
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):150-2, 189. PubMed ID: 1697234
[TBL] [Abstract][Full Text] [Related]
24. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells.
Prehn JL; Landers CJ; Targan SR
J Immunol; 1999 Oct; 163(8):4277-83. PubMed ID: 10510366
[TBL] [Abstract][Full Text] [Related]
25. Defective IFN-gamma production in the human neonate. I. Dysregulation rather than intrinsic abnormality.
Wakasugi N; Virelizier JL
J Immunol; 1985 Jan; 134(1):167-71. PubMed ID: 3917274
[TBL] [Abstract][Full Text] [Related]
26. [Effect of preliminary treatment with homologous interferon (priming) on the production of human immune interferon].
Aspetov RD; Novokhatskiĭ AS; Noskova VP; Ezepchuk IuV; Shuratov IKh
Antibiotiki; 1983 Mar; 28(3):214-8. PubMed ID: 6407389
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis.
Cosentino M; Zaffaroni M; Ferrari M; Marino F; Bombelli R; Rasini E; Frigo G; Ghezzi A; Comi G; Lecchini S
J Neuroimmunol; 2005 May; 162(1-2):112-21. PubMed ID: 15833366
[TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.
Bacon TH; Ozbakir F; Elms CA; Denman AM
Clin Exp Immunol; 1984 Sep; 57(3):541-7. PubMed ID: 6432387
[TBL] [Abstract][Full Text] [Related]
29. Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis.
Seitz M; Napierski I; Augustin R; Hunstein W; Kirchner H
Scand J Rheumatol; 1987; 16(4):257-62. PubMed ID: 3114875
[TBL] [Abstract][Full Text] [Related]
30. Generation of CFUC suppressor T cells in vitro. II. Effect of PHA, PWM, and Con-A on bone marrow and peripheral blood lymphocytes from healthy donors.
Podesta M; Frassoni F; van Lint MT; Piaggio G; Marmont A; Bacigalupo A
Exp Hematol; 1982 Mar; 10(3):256-62. PubMed ID: 6461560
[TBL] [Abstract][Full Text] [Related]
31. Interferon production by peripheral blood cells of patients with alcoholic liver disease (ALD).
Daniluk J; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 1994; 42(3):231-8. PubMed ID: 7487359
[TBL] [Abstract][Full Text] [Related]
32. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients.
Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313
[TBL] [Abstract][Full Text] [Related]
33. Production of high titre human interferon-gamma in primed leukocyte cultures.
Endrész V; Tóth S; Tóth M
Acta Microbiol Hung; 1985; 32(4):395-8. PubMed ID: 3012931
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients.
Schroecksnadel K; Winkler C; Werner ER; Sarcletti M; Romani N; Ebner S; Schennach H; Fuchs D; Zangerle R
Biol Chem; 2009 Feb; 390(2):115-23. PubMed ID: 19040353
[TBL] [Abstract][Full Text] [Related]
36. Long-term assessment of interferon responses in the HIV+ and AIDS patients.
Piasecki E; Knysz B; Inglot M; Simon K; Gładysz A
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):345-52. PubMed ID: 9017150
[TBL] [Abstract][Full Text] [Related]
37. Modulation of some Peyer's patch leukocyte functions following in vitro exposure to recombinant bovine alpha- and gamma-interferon.
Nagi AM; Babiuk LA
Immunobiology; 1988 Sep; 177(4-5):329-38. PubMed ID: 3143664
[TBL] [Abstract][Full Text] [Related]
38. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.
Jones BM
Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842
[TBL] [Abstract][Full Text] [Related]
39. [Effect of mitogens on the changes in intracellular cyclic AMP concentration in the lymphocytes of healthy persons and patients with lymphoblastic leukemia].
Konopka L; Karpowicz M; Malkowska-Zwierz W; Rechowicz K; Pawelski S
Acta Haematol Pol; 1980; 11(4):283-8. PubMed ID: 6270947
[TBL] [Abstract][Full Text] [Related]
40. Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans.
Crary B; Borysenko M; Sutherland DC; Kutz I; Borysenko JZ; Benson H
J Immunol; 1983 Feb; 130(2):694-7. PubMed ID: 6681539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
